Medtronic ROA 2010-2025 | MDT
Current and historical return on assets (ROA) values for Medtronic (MDT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Medtronic ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-04-30 | $4.66B | $91.68B | 5.16% |
| 2025-01-31 | $4.26B | $89.97B | 4.74% |
| 2024-10-31 | $4.29B | $90.04B | 4.76% |
| 2024-07-31 | $3.93B | $89.75B | 4.36% |
| 2024-04-30 | $3.68B | $89.98B | 4.07% |
| 2024-01-31 | $4.20B | $90.84B | 4.63% |
| 2023-10-31 | $4.10B | $90.09B | 4.48% |
| 2023-07-31 | $3.62B | $90.78B | 3.92% |
| 2023-04-30 | $3.76B | $90.95B | 4.08% |
| 2023-01-31 | $4.06B | $94.13B | 4.41% |
| 2022-10-31 | $4.32B | $93.24B | 4.72% |
| 2022-07-31 | $5.21B | $89.91B | 5.71% |
| 2022-04-30 | $5.04B | $90.98B | 5.50% |
| 2022-01-31 | $4.91B | $91.80B | 5.33% |
| 2021-10-31 | $4.70B | $91.76B | 5.03% |
| 2021-07-31 | $3.88B | $91.80B | 4.11% |
| 2021-04-30 | $3.61B | $93.08B | 3.79% |
| 2021-01-31 | $2.89B | $97.27B | 3.06% |
| 2020-10-31 | $3.54B | $95.89B | 3.79% |
| 2020-07-31 | $4.41B | $93.91B | 4.79% |
| 2020-04-30 | $4.79B | $90.69B | 5.24% |
| 2020-01-31 | $5.32B | $92.82B | 5.83% |
| 2019-10-31 | $4.67B | $91.05B | 5.18% |
| 2019-07-31 | $4.42B | $91.27B | 4.94% |
| 2019-04-30 | $4.63B | $89.69B | 5.20% |
| 2019-01-31 | $4.92B | $88.73B | 5.50% |
| 2018-10-31 | $2.26B | $88.15B | 2.48% |
| 2018-07-31 | $3.16B | $89.72B | 3.41% |
| 2018-04-30 | $3.10B | $91.39B | 3.25% |
| 2018-01-31 | $2.81B | $95.80B | 2.88% |
| 2017-10-31 | $5.02B | $94.46B | 5.12% |
| 2017-07-31 | $4.12B | $100.25B | 4.16% |
| 2017-04-30 | $4.03B | $99.86B | 4.08% |
| 2017-01-31 | $3.97B | $97.58B | 4.03% |
| 2016-10-31 | $4.24B | $98.41B | 4.25% |
| 2016-07-31 | $3.65B | $98.60B | 3.59% |
| 2016-04-30 | $3.54B | $99.64B | 3.44% |
| 2016-01-31 | $2.43B | $102.71B | 2.32% |
| 2015-10-31 | $2.32B | $104.95B | 2.49% |
| 2015-07-31 | $2.62B | $104.63B | 3.44% |
| 2015-04-30 | $2.68B | $106.69B | 4.49% |
| 2015-01-31 | $3.12B | $55.23B | 7.37% |
| 2014-10-31 | $2.91B | $38.78B | 7.68% |
| 2014-07-31 | $2.98B | $37.55B | 8.00% |
| 2014-04-30 | $3.07B | $37.94B | 8.36% |
| 2014-01-31 | $3.59B | $37.23B | 9.99% |
| 2013-10-31 | $3.81B | $36.47B | 10.79% |
| 2013-07-31 | $3.56B | $34.97B | 10.25% |
| 2013-04-30 | $3.47B | $34.90B | 10.12% |
| 2013-01-31 | $3.49B | $34.95B | 10.34% |
| 2012-10-31 | $3.44B | $33.96B | 10.41% |
| 2012-07-31 | $3.66B | $33.25B | 11.28% |
| 2012-04-30 | $3.62B | $32.82B | 11.34% |
| 2012-01-31 | $3.40B | $31.91B | 10.85% |
| 2011-10-31 | $3.39B | $31.75B | 10.93% |
| 2011-07-31 | $3.09B | $31.09B | 10.15% |
| 2011-04-30 | $3.10B | $30.68B | 10.39% |
| 2011-01-31 | $3.28B | $30.60B | 11.23% |
| 2010-10-31 | $3.18B | $29.31B | 11.44% |
| 2010-07-31 | $3.48B | $28.66B | 13.12% |
| 2010-04-30 | $3.10B | $28.09B | 12.26% |
| 2010-01-31 | $2.25B | $25.17B | 9.30% |
| 2009-10-31 | $2.11B | $24.28B | 8.97% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $118.964B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.730B | 26.59 |
| Boston Scientific (BSX) | United States | $152.695B | 36.41 |
| Stryker (SYK) | United States | $145.892B | 29.70 |
| EssilorLuxottica (ESLOY) | France | $145.168B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.349B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.447B | 24.82 |
| ResMed (RMD) | United States | $41.892B | 29.96 |
| Agilent Technologies (A) | United States | $33.562B | 21.88 |
| GE HealthCare Technologies (GEHC) | United States | $33.407B | 15.70 |
| Terumo (TRUMY) | Japan | $27.938B | 33.10 |
| Koninklijke Philips (PHG) | Netherlands | $26.432B | 17.48 |
| Insulet (PODD) | United States | $22.742B | 76.20 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.317B | 12.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.894B | 0.00 |
| Baxter (BAX) | United States | $12.127B | 9.37 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.703B | 28.30 |
| Lantheus Holdings (LNTH) | United States | $3.806B | 10.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.452B | 24.15 |
| Prestige Consumer Healthcare (PBH) | United States | $3.193B | 14.16 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $3.035B | 20.67 |
| Haemonetics (HAE) | United States | $2.559B | 11.42 |
| LeMaitre Vascular (LMAT) | United States | $2.151B | 46.14 |
| Curaleaf Holdings (CURLF) | Canada | $1.944B | 0.00 |
| AtriCure (ATRC) | United States | $1.770B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.753B | 11.03 |
| Green Thumb Industries (GTBIF) | United States | $1.751B | 75.18 |
| AdaptHealth (AHCO) | United States | $1.269B | 18.04 |
| Phibro Animal Health (PAHC) | United States | $1.267B | 16.19 |
| Tilray Brands (TLRY) | Canada | $1.255B | 0.00 |
| Neogen (NEOG) | United States | $1.203B | 19.10 |
| Acuren (TIC) | United States | $1.182B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 2450.00 |
| Valneva SE (VALN) | France | $1.033B | 0.00 |
| InMode (INMD) | Israel | $0.904B | 8.37 |
| Kestra Medical Technologies (KMTS) | United States | $0.826B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.654B | 0.00 |
| SNDL (SNDL) | Canada | $0.568B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.557B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.458B | 15.76 |
| CeriBell (CBLL) | United States | $0.447B | 0.00 |
| Evolus (EOLS) | United States | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.421B | 3.73 |
| Capricor Therapeutics (CAPR) | United States | $0.352B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.289B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Brainsway (BWAY) | Israel | $0.281B | 57.12 |
| Viemed Healthcare (VMD) | United States | $0.268B | 20.35 |
| Vireo Growth (VREOF) | United States | $0.244B | 0.00 |
| High Tide (HITI) | Canada | $0.242B | 0.00 |
| Cerus (CERS) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| Exagen (XGN) | United States | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.28 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.36 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.121B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.07 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.16 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.046B | 35.83 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |